Compare GENC & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GENC | CGC |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Pharmaceuticals and Biotechnology |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 254.2M | 299.0M |
| IPO Year | 1995 | 2023 |
| Metric | GENC | CGC |
|---|---|---|
| Price | $17.06 | $0.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $21.00 | $1.98 |
| AVG Volume (30 Days) | 38.1K | ★ 2.4M |
| Earning Date | 12-08-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.08 | ★ 84.17 |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $48,943,000.00 | $12,759,000.00 |
| Revenue This Year | $1.78 | $18.83 |
| Revenue Next Year | $25.68 | $7.72 |
| P/E Ratio | $19.72 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.22 | $0.64 |
| 52 Week High | $20.19 | $2.38 |
| Indicator | GENC | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 32.43 |
| Support Level | $16.88 | N/A |
| Resistance Level | $18.11 | $1.08 |
| Average True Range (ATR) | 0.53 | 0.04 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 43.90 | 20.47 |
Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.